PGI Chandigarh te Oxford Covid-19 vaccine trials

Sept 26, 2020: PGI Chandigarh Director Jagat Ram  koishe  Chandigarh based the Post Graduate Institute of Medical Education and Research (PGIMER) para Oxford Covid-19 vaccine — Covishield laga  akhe wala  dosage  toh tinta  candidates  ke  Friday din te dishe.

Jagat  Ram koishe Etu Oxford vaccine laga clinical trials  toh  PGI Chandigarh  te kurishe etu bi institute   khan para  vaccine  laga  akhe  wala  dosage diya  pichede  tinta  volunteers khan ke Friday te .

Ram koishe  duita maiki aro ekta mota  ke    0.5 ml laga  dosage dishe.tai koish”duita maiki   57 and 26 years aro ekta 44 umar  mota    ke  vaccine dishe    institute te”

PGIMER toh seventeen sites te ekta  ase kuntu te  phase II trials   ‘Covishield’ vaccine  Oxford University  para bona  toh ar o etu toh Pune based Serum Institute of India (SII) para bona toh  loi ase.

Etu  laga source  koishe  ki candidates khan ke 28 din nimete sabo    0.5 ml dose vaccine diya  pichede aro etu  pichede second dose   toh dibo etu  pichede 28 din sabole ase.

18 candidates khan ke etia  eligible paishe   etia  t ak etu trial jabole  nimete.Etu  pichede khoon laga  sample khan lobo aro etu toh choi  moina  nimete sabole ase.etu  ekla nohoikena  candidates  khan ke koishe      symptoms khan et u bukhar khan  ola t oh tai khan  laga diary te likhibole nimete janaishe.

Etu  institute khan bhabona kuri ase  100 candidates lobole nimete phase II study nimete aro etu  para  commitment  kurishe Indian Council of Medical Research (ICMR) ke 253  candidates nimete.

Etu trial  shuru kura toh institute khan para  safety  approval paa pichede kurishe   etu toh Data Safety and Monitoring Board (DSMB) pending thaka toh akhe wala  100 candidates   chuna  te  trials  nimete  juwa haafta.

Etu institute khan para akhe te koishe etu trials toh   September moina  laga  first week  para shuru kurishe  koikena.

Hoilebi etu toh diri kuridishe   safety approvals  khan rukhaiidya  nimete    candidates laga   DSMB para.

Etu pichede  trials toh  pan India  te  bondh kurishe Central Drugs Standard Control Organisation (CDSCO) para   etu  bi COVID-19 vaccine trials toh rukhaidiya  pichede United Kingdom (UK) te kile koile  toh etu te  ekta  bhaagh  luwa  manu    reaction   bisari ase   booster dose diya pichede.